| Structure | Chemical Name | CAS | MF |
|
(2R,4R)-2-(tert-Butyl)-3-(ethoxycarbonyl)-4-(indol-3-yl-Methyl]-1,3-oxazolidin-5-one
|
170458-96-5
|
C19H24N2O4
|
|
(2R,4R)-2-(tert-Butyl)-3-(ethoxycarbonyl)-4-(indol-3-yl-Methyl]-4-Methyl-1,3-oxazolidin-5-one
|
170458-97-6
|
C20H26N2O4
|
|
(S)-N-(Ethoxycarbonyl)-α-methyl-D-tryptophan Methyl Ester
|
170458-98-7
|
C16H20N2O4
|
|
9-(4-Nitrophenylethynyl)anthracene
|
170461-47-9
|
C22H13NO2
|
|
ACETAMIDE, N-[2-[4,5-DIMETHOXY-2-(TRIMETHYLSTANNYL)PHENYL]ETHYL]-2,2,2-TRIFLUORO-
|
170465-14-2
|
C15H22F3NO3Sn
|
|
6-ETHYL-7-HYDROXY-3-(4-METHYL-1,3-THIAZOL-2-YL)-4H-CHROMEN-4-ONE
|
170466-84-9
|
C15H13NO3S
|
|
4-(4-HYDROXY-3-METHOXYPHENYL)BUTAN-2-ONE OXIME
|
170467-02-4
|
C11H15NO3
|
|
2-Propenoic acid, 2-methyl-, butyl ester, polymer with 1,2-propanediol mono-2-propenoate
|
170475-04-4
|
|
|
Benzaldehyde, 3-fluoro-2-hydroxy-6-methoxy-
|
170482-99-2
|
C8H7FO3
|
|
4-Oxazolecarboxamide,N-methoxy-N-methyl-(9CI)
|
170486-48-3
|
C6H8N2O3
|
|
1,2-Benzisoxazol-7(4H)-one,5,6-dihydro-3-methyl-(9CI)
|
170487-35-1
|
C8H9NO2
|
|
4-Oxazolecarboxylic acid, methyl ester (9CI)
|
170487-38-4
|
C5H5NO3
|
|
2-Pyridinecarbonitrile,4-methyl-,1-oxide(9CI)
|
170487-39-5
|
C7H6N2O
|
|
Methyl 1H-indazole-6-carboxylate
|
170487-40-8
|
C9H8N2O2
|
|
1,4-dimethyl-1H-indole-3-carbaldehyde
|
170489-16-4
|
C11H11NO
|
|
4,7-DIMETHOXY-1H-INDOLE-3-CARBALDEHYDE
|
170489-17-5
|
C11H11NO3
|
|
6-ISOPROPYLINDOLE-3-CARBOXALDEHYDE
|
170489-34-6
|
C12H13NO
|
|
1-Boc-2-(2-Oxoethyl)Piperidine
|
170491-61-9
|
C12H21NO3
|
|
1-PYRROLIDINECARBOXYLIC ACID, 2-(2-OXOETHYL)-, 1,1-DIMETHYLETHYL ESTER
|
170491-62-0
|
C11H19NO3
|
|
2-HYDROXYMETHYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
|
170491-63-1
|
C10H19NO3
|
|
2-Morpholinothiazol-4-aMine hydrochloride
|
170492-30-5
|
C7H12ClN3OS
|
|
1-HYDROXY-6-(METHYLSULFONYL)INDOLE
|
170492-47-4
|
C9H9NO3S
|
|
2,5-DIBROMOBENZAMIDE
|
170492-50-9
|
C7H5Br2NO
|
|
1H-Indene-2-acetaldehyde,6-ethoxy-2,3-dihydro-1-oxo-(9CI)
|
170495-71-3
|
C13H14O3
|
|
2H-Imidazol-2-one,1-amino-1,3-dihydro-3,4-dimethyl-(9CI)
|
170500-49-9
|
C5H9N3O
|
|
2-Imidazolidinone,1-amino-3,4-dimethyl-(9CI)
|
170500-50-2
|
C5H11N3O
|
|
2(1H)-Pyrimidinone,1-aminotetrahydro-4-methyl-(9CI)
|
170500-56-8
|
C5H11N3O
|
|
2(1H)-Pyrimidinone,1-amino-3,4-dihydro-4-methyl-(9CI)
|
170500-60-4
|
C5H9N3O
|
|
2H-Imidazol-2-one,3-amino-1,3-dihydro-1,4-dimethyl-(9CI)
|
170500-61-5
|
C5H9N3O
|
|
2(1H)-Pyrimidinone,1-amino-3,4-dihydro-6-methyl-(9CI)
|
170500-65-9
|
C5H9N3O
|
|
1,2,4-Triazin-3(2H)-one,4-aminotetrahydro-6-methyl-(9CI)
|
170501-06-1
|
C4H10N4O
|
|
3-Furancarboxaldehyde, 5-ethoxytetrahydro-2-oxo-, trans- (9CI)
|
170501-44-7
|
C7H10O4
|
|
3-Furancarboxaldehyde, 5-ethyltetrahydro-2-oxo-, trans- (9CI)
|
170501-45-8
|
C7H10O3
|
|
3-Furancarboxaldehyde, tetrahydro-3,4-dimethyl-2-oxo-, cis- (9CI)
|
170501-51-6
|
C7H10O3
|
|
3-Furancarboxaldehyde, tetrahydro-3,4-dimethyl-2-oxo-, trans- (9CI)
|
170501-52-7
|
C7H10O3
|
|
3-Furancarboxaldehyde, 5-ethyltetrahydro-3-methyl-2-oxo-, cis- (9CI)
|
170501-56-1
|
C8H12O3
|
|
3-Furancarboxaldehyde, 5-ethyltetrahydro-3-methyl-2-oxo-, trans- (9CI)
|
170501-57-2
|
C8H12O3
|
|
Ethanol, 2-[(3-methyl-2-pyridinyl)oxy]- (9CI)
|
170502-08-6
|
C8H11NO2
|
|
1,3-Benzenedicarboxaldehyde,2-fluoro-(9CI)
|
170502-72-4
|
C8H5FO2
|
|
1H-Imidazole-5-carboxylicacid,4,5-dihydro-1,2,4-trimethyl-,methylester(9CI)
|
170504-14-0
|
C8H14N2O2
|
|
Methyl 6-((tert-butoxycarbonyl)aMino)spiro[3.3]heptane-2-carboxylate
|
170508-14-2
|
C14H23NO4
|
|
25-HydroxyvitaMin D3 3-Glucuronide
|
170512-14-8
|
C33H52O8
|
|
N-UNDECYL-BETA-D-MALTOSIDE
|
170552-39-3
|
C23H44O11
|
|
Ethanone, 1-[2-(1-hydroxy-2-methylpropyl)cyclopropyl]-, [1alpha,2alpha(R*)]- (9CI)
|
170552-90-6
|
C9H16O2
|
|
Ethanone, 1-[2-(2-methyl-1-propenyl)cyclopropyl]-, (1S-trans)- (9CI)
|
170552-91-7
|
C9H14O
|
|
Alanine, 3-amino-2-methyl- (9CI)
|
170554-69-5
|
C4H10N2O2
|
|
antazirine
|
170554-75-3
|
C17H25Br2NO2
|
|
|
Boric acid (H3BO3), reaction products with diethylene glycol and polyethylene glycol mono-Me ether
|
170557-43-4
|
|
|
(R)-1-Phenyl-3-propanolamine
|
170564-98-4
|
C9H13NO
|
|
4-CYANOPHENYL CYCLOPROPYL KETONE
|
170564-99-5
|
C11H9NO
|
|
N,N-dimethyl-2-oxo-1,3-dihydroindole-5-sulfonamide
|
170565-89-6
|
C10H12N2O3S
|
|
Lanepitant
|
170566-84-4
|
C33H45N5O3
|
|
Piperazine, 2,2,6-trimethyl-, (S)- (9CI)
|
170568-91-9
|
C7H16N2
|
|
4-[5-(4-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
|
170569-86-5
|
C16H11ClF3N3O2S
|
|
1-HEXADECANOYL-2-(P-NITROPHENOXYSUCCINOYL)-SN-GLYCERYL-3-PHOSPHORYLCHOLINE
|
170569-87-6
|
C16H12F3N3O2S
|
|
4-[5-(4-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)PYRAZOL-1-YL]BENZENE-1-SULFONAMIDE
|
170569-88-7
|
C16H11F4N3O2S
|
|
Celecoxib 2-Methyl Analog
|
170569-99-0
|
C17H14F3N3O2S
|
|
4-DesMethyl-3-Methyl Celecoxib
|
170570-01-1
|
C17H14F3N3O2S
|
|
Celecoxib Impurity
|
170570-09-9
|
C18H16F3N3O2S
|
|
Dehydroxy BroMocelecoxib
|
170570-75-9
|
C17H13BrF3N3O2S
|
|
1-(4-CHLORO-PHENYL)-4,4-DIFLUORO-BUTANE-1,3-DIONE
|
170570-76-0
|
C10H7ClF2O2
|
|
4,4-difluoro-1-(3-fluoro-4-methoxyphenyl)butane-1,3-dione
|
170570-77-1
|
C11H9F3O3
|
|
3,5-DIFLUORO-4-METHOXYACETOPHENONE
|
170570-79-3
|
C9H8F2O2
|
|
HYDROXYMETHYL CELECOXIB
|
170571-00-3
|
C17H14F3N3O3S
|
|
CELECOXIB CARBOXYLIC ACID
|
170571-01-4
|
C17H12F3N3O4S
|
|
1-[4-(Aminosulfonyl)Phenyl]-5-(4-Chlorophenyl)-1H-Pyrazole-3-Carboxylic Acid(WXC04274)
|
170571-19-4
|
C16H12ClN3O4S
|
|
METHYL 1-[4-(AMINOSULFONYL)PHENYL]-5-(4-CHLOROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
|
170571-20-7
|
C17H14ClN3O4S
|
|
2,5,8,11,14,17,20-Heptaoxadocosan-22-amine
|
170572-38-0
|
C15H33NO7
|
|
3,5-difluoro-4-hydroxybenzoic acid Methyl ester
|
170572-47-1
|
C8H6F2O3
|
|
1,3-Difluoro-2-methyl-5-nitrobenzene
|
170572-48-2
|
C7H5F2NO2
|
|
3-Fluoro-4-methylbenzonitrile
|
170572-49-3
|
C8H6FN
|
|
Benzonitrile, 3,5-difluoro-4-methyl- (9CI)
|
170572-50-6
|
C8H5F2N
|
|
4-Chloro-2,6-difluorophenyl methyl ether, 5-Chloro-1,3-difluoro-2-methoxybenzene
|
170572-51-7
|
C7H5ClF2O
|
|
1,3-Cyclohexanediamine,4-(1-methylethyl)-(9CI)
|
170572-96-0
|
C9H20N2
|
|
5-ETHYL-1,3,4-THIADIAZOL-2-YLBORONIC ACID
|
170573-24-7
|
C4H7BN2O2S
|
|
L-LeucinaMide,N-[(phenylMethoxy)carbonyl]-L-leucyl-L-leucyl-N-Methoxy-N-Methyl-
|
170590-15-5
|
C28H46N4O6
|
|
oteromycin
|
170591-45-4
|
C32H41NO3
|
|
|
SLR3 protein
|
170620-44-7
|
|
|
GLYCINE, N-[[3-METHOXY-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL]CARBONYL]-, ETHYL ESTER
|
170621-40-6
|
C13H15F3N2O5
|
|
2-PYRIDINECARBOXYLIC ACID, 3-METHOXY-4-(2,2,2-TRIFLUOROETHOXY)-
|
170621-84-8
|
C9H8F3NO4
|
|
(4-chloro-3-Methoxypyridin-2-yl)Methanol
|
170621-85-9
|
C7H8ClNO2
|
|
4-CHLORO-3-METHOXYPYRIDINE-2-CARBOXYLIC ACID
|
170621-86-0
|
C7H6ClNO3
|
|
3-Isoquinolinecarboxylicacid,4-methoxy-(9CI)
|
170621-98-4
|
C11H9NO3
|
|
YC-1
|
170632-47-0
|
C19H16N2O2
|
|
Guanidine, N-cyano-N-[(2-ethoxyphenyl)methyl]- (9CI)
|
170634-21-6
|
C11H14N4O
|
|
2,2'-(HYDROXYNITROSOHYDRAZONO)BIS-ETHANIMINE
|
170637-66-8
|
C4H13N5O2
|
|
(R)-7-METHOXY-1,2,3,4-TETRAHYDRO-NAPHTHALEN-2-YLAMINE HYDROCHLORIDE
|
170638-05-8
|
C11H16ClNO
|
|
Boc-2-Methoxy-D-Phenylalanine
|
170642-26-9
|
C15H21NO5
|
|
FMOC-D-ABU-OH
|
170642-27-0
|
C19H19NO4
|
|
(R)-N-Fmoc-Allylglycine
|
170642-28-1
|
C20H19NO4
|
|
FMOC-D-CYCLOPROPYLALANINE
|
170642-29-2
|
C21H21NO4
|
|
Fmoc-2-Methoxy-D-Phenylalanine
|
170642-30-5
|
C25H23NO5
|
|
2-Methoxy-D-Phenylalanine
|
170642-31-6
|
C10H13NO3
|
|
FMOC-D-ALLO-THR(TBU)-OH
|
170643-02-4
|
C23H27NO5
|
|
ETHYL 2 4 5-TRIETHOXYBENZOATE 97
|
170645-86-0
|
C15H22O5
|
|
Benzene, 1,3-difluoro-5-(fluoromethyl)- (9CI)
|
170646-72-7
|
C7H5F3
|
|
N-METHOXY-N-METHYL-3-PHENYL-PROPIONAMIDE
|
170646-96-5
|
C11H15NO2
|
|
3-Isoxazolecarboxylicacid,4,5-dihydro-5-hydroxy-,methylester(9CI)
|
170648-38-1
|
C5H7NO4
|
|
3-Isoxazolebutanoicacid(9CI)
|
170648-43-8
|
C7H9NO3
|
|
Isoxazole, 3-(2,2-dimethoxyethyl)- (9CI)
|
170648-44-9
|
C7H11NO3
|